Drug Approval | August 13, 2025
Indoco Remedies receives final USFDA approval for rivaroxaban tablets
Rivaroxaban is used to treat venous thromboembolism
Rivaroxaban is used to treat venous thromboembolism
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Prucalopride is prescribed for chronic idiopathic constipation
Subscribe To Our Newsletter & Stay Updated
